Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure The CAMELOT Study: A Randomized Controlled Trial

By S. Nissen, E. Tuzcu, Peter Libby, P. Thompson, M. Ghali, D. Garza, L. Berman, Harry Shi, Ethel Buebendorf, Eric J. Topol and 1 more. 2004

728 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013, background): “In fact, in all trials in which the design permitted or prescribed the simultaneous use of diuretics, beta-blockers or ACE inhibitors [269,299,301, 423], calcium antagonists were not inferior to comparative therapies in preventing heart failure.”
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007, result): “A reduction of cardiovascular events was also observed in the CAMELOT trial in treated coronary patients in whom the addition of amlodipine reduced blood pressure by few mmHg compared to placebo.(305) Surprisingly, another trial in coronary patients and with similar blood pressure differences in whi”